Diagnostic flexible bronchoscopy in human immunodeficiency virus (HIV)-positive children. NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Diagnostic flexible bronchoscopy in human immunodeficiency virus (HIV)-positive children.

Int J Pediatr Otorhinolaryngol. 1989 Dec;18(2):119-27. Unique Identifier : AIDSLINE MED/90170290
Sculerati N; Ambrosino MM; Avni-Singer AJ; Horwitz DA; Lawrence RM; Department of Otolaryngology, New York University Medical Center,; New York.

Abstract: Twelve children with laboratory evidence of human immunodeficiency virus (HIV) infection underwent diagnostic flexible bronchoscopy with washings or bronchoalveolar lavage at Bellevue Hospital Center from October 1987 to April 1989. The patients included 7 boys and 5 girls ranging from age 3.5 months to 10 years 5 months. Indications for bronchoscopy included respiratory distress with or without focal changes on chest radiograph in 11 patients, and persistent but asymptomatic right middle lobe collapse in one child. The etiology of pneumonia was diagnosed in 7 children and included Pneumocystis carinii, (PCP) (17%), Streptococcus viridans (17%), mechanical obstruction (17%) and cytomegalovirus (CMV) (8%). Bronchoscopy was non-diagnostic in 5 cases. Techniques for maximal yield of information using flexible bronchoscopy in HIV-positive children are discussed.
Keywords: Bronchoalveolar Lavage Fluid/MICROBIOLOGY Bronchoscopy/*METHODS Child Child, Preschool Female Human HIV Infections/*DIAGNOSIS Infant Male JOURNAL ARTICLEKWDbronchoalveolarlavagefluid/microbiologybronchoscopy/KWDmethodschildchild,preschoolfemalehumanhivinfections/KWDdiagnosisinfantmalejournalarticle
900630
M9060613

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .